Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

UPDATE 2-London stocks climb as AstraZeneca, Indivior jumps

Published 01/26/2021, 05:29 PM
Updated 01/27/2021, 01:20 AM
© Reuters.

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Indivior top mid-cap gainer
* Rolls-Royce tumbles on lower engine travel expectations
* UK's unemployment rate jumps to highest since 2016
* FTSE 100 rises 0.2%, FTSE 250 adds 0.5%

(Updates to close)
By Shashank Nayar and Amal S
Jan 26 (Reuters) - British stocks ended higher on Tuesday
after drugmaker AstraZeneca denied reports that its COVID-19
vaccine was less effective in the elderly population, while
Indivior surged after its former parent withdrew a $1.4 billion
legal claim.
The blue-chip FTSE 100 index .FTSE climbed 0.2%, with
automakers .FTNMX3350 and healthcare stocks .FTNMX4530
leading the gains, while the mid-cap index .FTMC rose 0.5%.
However, weakness in general retailers .FTNMX5370 limited
gains after British retail sales suffered their biggest annual
drop since May this month, suggesting the latest lockdown is
taking a heavy toll on many shops. The mood was also dampened by a jump in Britain's
unemployment rate to 5.0%, its highest in nearly five years, in
the three months to November. "Even though the unemployment rate is at 5%, it was meant to
go to 5.1%. So, there were positive angles to pick among the
negative news and I think that seems to have benefited
sentiment alongside the pound falling," said Connor Campbell, a
financial analyst at SpreadEx.
Drugmaker AstraZeneca AZN.L gained 0.7% and gave the
second biggest boost to the blue-chip index after it denied
reports its COVID-19 vaccine was not very effective for people
over 65.
The FTSE 100 has recorded consistent monthly gains since
November on expectations of a vaccine-led recovery, but it has
lost steam as extended lockdowns hit business activity.
The International Monetary Fund cut Britain's growth outlook
for 2021 because of a resurgence in novel coronavirus cases, and
forecast it would take until next year for the economy to regain
its pre-pandemic strength. Britain's Rolls-Royce RR.L dropped 1.8% after it
downgraded expectations for how much its engines would fly this
year. Indivior INDV.L leapt 13.1% to the top of the FTSE 250
index after it said late on Monday that former parent Reckitt
Benckiser RB.L would withdraw a $1.4 billion claim against the
company.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.